United StatesAn FDA toxicologist, Christy Leppanen, claims the U.S. Food and Drug Administration authorized Zyn nicotine pouches for sale without fully understanding their composition. During informal testing at home, she discovered that the pouches did not dissolve as previously believed, raising concerns about potential health and environmental risks. Despite her efforts to highlight these issues within the agency, her warnings were largely ignored. The FDA later approved Zyn, citing an environmental review that Leppanen had supposedly endorsed, though this was later corrected. Scientists warn that the pouches might release microplastics, which could pose health risks as they accumulate in human organs.
Bias read (Progressive): The article highlights regulatory oversight failures and raises concerns about public health and environmental impact, suggesting criticism of the FDA's decision-making process and alignment with public interest over corporate interests.
